17:55 EST Novo Nordisk (NVO) says Wegovy pill approved in U.S. as oral GLP-1, Bloomberg reports
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVO:
- Moderately bullish activity in Novo Nordisk with shareslittle changed
- Novo Nordisk call volume above normal and directionally bullish
- Mixed options sentiment in Novo Nordisk with shares up 1.27%
- Mixed options sentiment in Novo Nordisk with shares down 0.22%
- Eli Lilly (LLY) Says Obesity Pill Helps Maintain Weight Loss as Patients Switch from Zepbound